| 发明名称 |
USE OF PAN FGFR INHIBITORS AND METHOD OF IDENTIFYING PATIENTS WITH CANCER ELIGIBLE FOR TREATMENT WITH A PAN FGFR INHIBITOR |
| 摘要 |
The current invention is based on a pan FGFR inhibitor for use in the treatment of cancer in a subject, wherein the subject is one for whom the sum of FGFR1, FGFR2 and/ or FGFR3 mRNA in a tumor tissue sample from the subject has been found to be overexpressed. |
| 申请公布号 |
WO2016091849(A3) |
申请公布日期 |
2016.07.28 |
| 申请号 |
WO2015EP78919 |
申请日期 |
2015.12.08 |
| 申请人 |
BAYER PHARMA AKTIENGESELLSCHAFT |
发明人 |
ELLINGHAUS, PETER;HEROULT, MELANIE |
| 分类号 |
A61K31/4184;A61K31/4965;A61K31/498;A61K31/506;A61K31/53;A61P35/00 |
主分类号 |
A61K31/4184 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
